Bell Investment Advisors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.78K Hold
86
﹤0.01% 1220
2026
Q1
$1.58K Hold
86
﹤0.01% 1404
2025
Q4
$1.36K Buy
86
+29
+51% +$518 ﹤0.01% 1471
2025
Q3
$1.1K Hold
57
﹤0.01% 1532
2025
Q2
$1.18K Hold
57
﹤0.01% 1538
2025
Q1
$1.4K Sell
57
-41
-42% -$1.05K ﹤0.01% 1440
2024
Q4
$2.35K Sell
98
-25
-20% -$794 ﹤0.01% 1268
2024
Q3
$5.21K Buy
123
+6
+5% +$315 ﹤0.01% 913
2024
Q2
$5.99K Sell
117
-16
-12% -$907 ﹤0.01% 837
2024
Q1
$8.31K Hold
133
﹤0.01% 667
2023
Q4
$9.96K Buy
133
+33
+33% +$2.36K ﹤0.01% 562
2023
Q3
$8.52K Sell
100
-7
-7% -$664 ﹤0.01% 574
2023
Q2
$11.7K Buy
107
+22
+26% +$2.09K ﹤0.01% 458
2023
Q1
$7.05K Buy
85
+13
+18% +$1.22K ﹤0.01% 617
2022
Q4
$7.4K Sell
72
-5
-6% -$576 ﹤0.01% 612
2022
Q3
$8K Buy
77
+3
+4% +$329 ﹤0.01% 468
2022
Q2
$8K Buy
+74
New +$7.33K ﹤0.01% 482
2021
Q4
$8K Buy
67
+12
+22% +$1.33K ﹤0.01% 540
2021
Q3
$6K Buy
+55
New +$5.83K ﹤0.01% 605

Other funds holding AMN

Bell Investment Advisors's AMN Position: Q2 2026 in Review

Bell Investment Advisors held its AMN Healthcare (AMN) position steady in Q2 2026 at 86 shares worth $2.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1220.

Bell Investment Advisors first reported a position in AMN in Q3 2021 and has held it in 19 quarters since. The position peaked at $11.7K in Q2 2023. 284 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Bell Investment Advisors held 86 shares of AMN Healthcare worth $2.78K as of Q2 2026.
  • Bell Investment Advisors left its AMN Healthcare share count unchanged in Q2 2026.
  • AMN Healthcare made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1220 holding.
  • Bell Investment Advisors first reported a position in AMN Healthcare in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's AMN Healthcare position peaked at $11.7K in Q2 2023.
  • 284 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.